ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

In Brief: Bailes Elected President Of ASCO For 1999; Outlines Goals In Remarks To ACCC

March 20, 1998

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012